Results 151 to 160 of about 7,138,752 (240)

Relationship Between <i>Clostridioides difficile</i> Stool Concentration, Nucleic Acid Amplification Test Results, and Environmental Contamination. [PDF]

Open Forum Infect Dis
Lee MM, Reske KA, Hink T, Fishbein SRS, Newcomer EP, Cass C, Olsen MA, Dantas G, Burnham CD, Dubberke ER.   +9 more
europepmc   +1 more source

Somatic mutational landscape in von Hippel–Lindau familial hemangioblastoma

Molecular Oncology, EarlyView.
The causes of central nervous system (CNS) hemangioblastoma in Von Hippel–Lindau (vHL) disease are unclear. We used Whole Exome Sequencing (WES) on familial hemangioblastoma to investigate events that underlie tumor development. Our findings suggest that VHL loss creates a permissive environment for tumor formation, while additional alterations ...
Maja Dembic, Anne Nørremølle, Lilian Bomme Ousager, Lars van Brakel Andersen, Marie Louise Mølgaard Binderup, Mads Thomassen   +5 more
wiley   +1 more source

Test Result [PDF]

Chemical & Engineering News Archive, 1983
openaire   +1 more source

Dual PI3K/AKT and CDK4/6 inhibition reveals selective sensitivity in an SHH medulloblastoma stem cell model

Molecular Oncology, EarlyView.
Targeted therapy was evaluated in SHH medulloblastoma using neuroepithelial stem cell (NES) and tumor‐derived NES‐like (tNES) models in 2D monolayers and 3D spheroids. PI3K, AKT, and CDK4/6 inhibitors had minimal effects in NES but markedly reduced viability and growth and induced apoptosis in tNES cells, revealing distinct therapeutic vulnerabilities.
Monika Lukoseviciute, Madeleine Birgersson, Paolo Ceriani, Margareta Wilhelm, Ourania N Kostopoulou   +4 more
wiley   +1 more source

Test results and follow-up care stemming from an ED-based cervical cancer intervention. [PDF]

Am J Emerg Med
Abar B, Wood N, Merriman J, Adler D.
europepmc   +1 more source

Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy

Molecular Oncology, EarlyView.
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric, Line Bjørge, Martine Rott Lode, Cecilie Fredvik Torkildsen, Pia Aehnlich, Rammah Elnour, Daniela Elena Costea, Lars Andreas Akslen, Liv Cecilie Vestrheim Thomsen, Emmet McCormack, Katrin Kleinmanns   +10 more
wiley   +1 more source

Measurement uncertainty of ISO 17511:2020 compliant and globally standardized PT/INR test results. [PDF]

Res Pract Thromb Haemost
van der Helm MP, van Rijn CJJ, Baktawar SS, Abdoel CF, Kitchen S, Bryant M, Brown P, Tripodi A, Scalambrino E, Clerici M, Herbel P, Jünschke A, Meijer P, Stavelin A, Thelwell C, Cobbaert CM, van den Besselaar AMHP.   +16 more
europepmc   +1 more source

Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer

Molecular Oncology, EarlyView.
Dysregulation of the Hippo pathway drives nuclear accumulation of YAP/TAZ, activating stemness‐related transcriptional programs that sustain breast cancer stemness and fuel therapeutic resistance across subtypes, underscoring Hippo signaling as a targetable vulnerability. Figure created and edited with BioRender.com.
Giulia Schiavoni, Antonella Palmese, Stefano Scalera, Laura Cipriani, Davide Mascolo, Patrizia Vici, Teresa Arcuri, Lorena Filomeno, Eriseld Krasniqi, Giovanni Blandino, Giulia Bon, Marcello Maugeri‐Saccà   +11 more
wiley   +1 more source

Patient portal access to diagnostic test results

Journal of Pathology Informatics, 2018
Beuy Joob, Viroj Wiwanitkit
doaj   +1 more source

Factors Associated With Inaccurate Recall of Inherited Cancer Genetic Test Results Among Individuals With Germline Pathogenic Variants. [PDF]

Cancer Med
Cragun DL, Sears BF, Bharwani KP, Weidner AE, Beckstead JW, Pal T.   +5 more
europepmc   +1 more source